[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340271-105":59,"doc-detail-340271-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","modulation-of-the-oncogenic-line-1-regulatory-network-in-non-small-cell-lung-cancer-by-exosomal-mirnas","Modulation of the Oncogenic LINE-1 Regulatory Network in Non-Small Cell Lung Cancer by Exosomal miRNAs","","Several microRNAs (miRNAs), including miR-221-5p, Let-7b-5p, miR-21-5p, miR-9-5p, miR-126-3p, and miR-222-3p, are enriched in circulating exosomes from non-small cell lung cancer (NSCLC) patients and can distinguish cancer cases from controls with high precision. To test whether they regulate the oncogenic LINE-1 network, plasma exosomes from controls, early-, and late-stage NSCLC were co-cultured with non-tumorigenic lung epithelial cells for 72 h. Late-stage exosomes markedly increased LINE-1 ORF1/ORF2 and key target miRNAs, activating oncogenic targets such as ICAM1, AGL, RGS3, RGS13, VCAM1, and TGFβ1, whereas control/early-stage exosomes inhibited these pathways.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/modulation-of-the-oncogenic-line-1-regulatory-network-in-non-small-cell-lung-cancer-by-exosomal-mirnas/340271/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/modulation-of-the-oncogenic-line-1-regulatory-network-in-non-small-cell-lung-cancer-by-exosomal-mirnas/340271.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Which microRNAs and exosomal signals are reported as enriched in NSCLC patients?","Question",{"text":113,"@type":114},"The article reports enrichment of miR-221-5p, Let-7b-5p, miR-21-5p, miR-9-5p, miR-126-3p, and miR-222-3p in circulating exosomes from NSCLC patients.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were exosomal effects tested in the study?",{"text":118,"@type":114},"Plasma exosomes from controls, early-stage, and late-stage NSCLC patients were co-cultured with non-tumorigenic lung epithelial cells for 72 hours, followed by gene expression measurements.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the main difference between late-stage NSCLC exosomes and control/early-stage exosomes?",{"text":122,"@type":114},"Late-stage NSCLC exosomes activate LINE-1 and miRNA-regulated oncogenic signaling, increasing LINE-1 ORF1/ORF2 and multiple oncogenic targets, while control or early-stage exosomes inhibit LINE-1 expression and many LINE-1 network targets.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},340271,1790104120,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article  \nModulation of the Oncogenic LINE-1 Regulatory Network in Non-Small Cell Lung Cancer by Exosomal miRNAs  \nAbeer A. I. Hassanin 1,2 and Kenneth S. Ramos 1, *  \nCitation: Hassanin, A.A.I.; Ramos, K.S. Modulation of the Oncogenic LINE-1 Regulatory Network in Non-Small Cell Lung Cancer by Exosomal miRNAs. Int. J. Mol. Sci. 2024, 25, 10674. [https://](https://)[ ](https://)[doi.org/10.3390/ijms251910674](doi.org/10.3390/ijms251910674)  \nAcademic Editor: Ida Daniela Perrotta  \nReceived: 14 September 2024  \nRevised: 26 September 2024  \nAccepted: 1 October 2024  \nPublished: 3 October 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Center for Genomic and Precision Medicine, Texas Medical Center, Texas A&M Institute of Biosciences and Technology, Houston, TX 77030, USA; [ahassanin@tamu.edu](ahassanin@tamu.edu)  \n2 Department of Animal Wealth Development, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt  \n* Correspondence: [kramos@tamu.edu](kramos@tamu.edu)  \nAbstract: Several microRNAs (miRNAs), including miR-221-5p, Let-7b-5p, miR-21-5p, miR-9-5p, miR-126-3p, and miR-222-3p, were recently found to be enriched in circulating exosomes of patients with non-small cell lung cancers (NSCLCs) . These miRNAs distinguished cancer cases from controls with high precision and were predicted to modulate the expression of genes within the oncogenic LINE-1 regulatory network. To test this hypothesis, plasma exosomes from controls, early, and late-stage NSCLC patients were co-cultured with non-tumorigenic lung epithelial cells for 72 h and processed for measurements of gene expression. Exosomes from late-stage NSCLC patients markedly increased the mRNA levels of LINE-1 ORF1 and ORF2, as well as the levels of target miRNAs innaïve recipient cells compared to saline or control exosomes. Late-stage exosomes also modulated the expression of oncogenic targets within the LINE-1 regulatory network, namely, ICAM1, AGL, RGS3, RGS13, VCAM1, and TGFβ1 . In sharp contrast, exosomes from controls or early-stage NSCLC patients inhibited LINE-1 expression, along with many of the genetic targets within the LINE-1 regulatory network. Thus, late-stage NSCLC exosomes activate LINE-1 and miRNA-regulatedoncogenic signaling in non-tumorigenic, recipient lung bronchial epithelial cells. These findings raise important questions regarding lung cancer progression and metastasis and open the door for the exploration of new therapeutic interventions.  \nKeywords: plasma exosomes; LINE-1; microRNA profiles; oncogenic signaling; non-small cell lung cancer  \n1. Introduction  \nLung cancer continues to be the primary cause of cancer-related mortality in the United States, accounting for approximately 1.8 million deaths in 2022 [1] . Non-small cell lung cancers (NSCLCs) account for more than 85% of all lung cancer cases and are classified by histological subtype into squamous cell lung cancers (SQCLCs), lung adenocarcinomas (LUADs), adeno-squamous carcinomas, and large cell carcinomas [2–4] . Metastasis is a significant contributor to mortality in patients with lung cancer, where exosomes and their cargos, together with microenvironmental influences, play crucial roles in facilitating tumor migration and invasion [5,6] . Recent evidence indicates that exosomes transport physiologically active components to distant sites and organs, therefore guiding metastasis by creating metastatic pre-niches and promoting tumor development [7,8] . Cancer cells release considerably larger numbers of exosomes than normal cells, with tumor-derived exosomes transferring their RNA, miRNA, and protein cargos to recipient cells to modulate cellular functio","cbCaipvleEjA5EY9","https://ap.wps.com/l/cbCaipvleEjA5EY9","pdf",11811990,16,"English","# Abstract\n# Introduction\n## Epidemiology and clinical context of NSCLC\n## Exosomes and microRNAs in metastasis\n## LINE-1 and miRNA-linked regulatory interactions\n# Study aim and experimental concept","[{\"question\":\"Which microRNAs and exosomal signals are reported as enriched in NSCLC patients?\",\"answer\":\"The article reports enrichment of miR-221-5p, Let-7b-5p, miR-21-5p, miR-9-5p, miR-126-3p, and miR-222-3p in circulating exosomes from NSCLC patients.\"},{\"question\":\"How were exosomal effects tested in the study?\",\"answer\":\"Plasma exosomes from controls, early-stage, and late-stage NSCLC patients were co-cultured with non-tumorigenic lung epithelial cells for 72 hours, followed by gene expression measurements.\"},{\"question\":\"What is the main difference between late-stage NSCLC exosomes and control/early-stage exosomes?\",\"answer\":\"Late-stage NSCLC exosomes activate LINE-1 and miRNA-regulated oncogenic signaling, increasing LINE-1 ORF1/ORF2 and multiple oncogenic targets, while control or early-stage exosomes inhibit LINE-1 expression and many LINE-1 network targets.\"}]","Modulation of the Oncogenic LINE-1 Regulatory Network in Non-Small Cell Lung Cancer by Exosomal miRNAs | PDF",1790035450,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc0392da63b2d54e578b974947fcb09d.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e9502fb88226eb9ff0b8aec30bc3bc8.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7d2c4f1b469c17c65abf50a0ea2edfd.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6fc3c15dfda5f353aa01e67752af9c2.webp",980,1385]